KORU Medical Systems, Inc. KRMD shares soared 5.6% in the last trading session to close at $5.69. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the stock's 3.9% loss over the past four weeks.
KORU Medical Systems scored a strong price increase on investors’ optimism surrounding the latest FDA clearance for use of the FreedomEDGE infusion system to deliver RYSTIGGO (rozanolixizumab-noli). Freedom Infusion System enables, simplifies, and enhances the delivery of large-volume subcutaneous drugs.
This company is expected to post quarterly loss of $0.02 per share in its upcoming report, which represents a year-over-year change of +33.3%. Revenues are expected to be $10.89 million, up 23.2% from the year-ago quarter.
While earnings and revenue growth expectations are important in evaluating the potential strength in a stock, empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements.
For KORU Medical Systems, Inc., the consensus EPS estimate for the quarter has remained unchanged over the last 30 days. And a stock's price usually doesn't keep moving higher in the absence of any trend in earnings estimate revisions. So, make sure to keep an eye on KRMD going forward to see if this recent jump can turn into more strength down the road.
The stock currently carries a Zacks Rank #2 (Buy). You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>
KORU Medical Systems, Inc. is part of the Zacks Medical Info Systems industry. Claritev Corporation CTEV, another stock in the same industry, closed the last trading session 2.3% higher at $27.78. CTEV has returned -19.9% in the past month.
Claritev Corporation's consensus EPS estimate for the upcoming report has remained unchanged over the past month at -$3.96. Compared to the company's year-ago EPS, this represents a change of +23%. Claritev Corporation currently boasts a Zacks Rank of #3 (Hold).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
KORU Medical Systems, Inc. (KRMD): Free Stock Analysis Report Claritev Corporation (CTEV): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).
Zacks Investment Research
